News
Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment optionsPhase II data show ...
Liver fibrosis is a gradually worsening condition marked by excessive collagen buildup resulting from ongoing liver damage.
A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works ...
Researchers at the University of Oklahoma report a hormone, FGF21, may reverse fatty liver disease by signaling the brain.
Altimmune's Q1 2025 earnings call highlights breakthroughs in NASH treatments, robust financials with a new $100M credit facility, and imminent Phase ...
Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany ParticipantsLee Roth - President, Burns McClellan, ...
A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
On a quest to expand the eligible patient pool for its fast-growing liver disease drug Rezdiffra, Madrigal Pharmaceuticals ...
Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results